ISSN 1977-091X

Official Journal

of the European Union

C 208

European flag  

English edition

Information and Notices

Volume 62
19 June 2019


Contents

page

 

IV   Notices

 

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

 

European Commission

2019/C 208/01

Euro exchange rates

1

2019/C 208/02

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)  ( 1 )

2

2019/C 208/03

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006)  ( 1 )

3

 

NOTICES FROM MEMBER STATES

2019/C 208/04

Winding-Up Proceedings — Decision to start winding-up proceedings in respect of LAMP Insurance Company Limited (Publication made in accordance with Article 280 of Directive 2009/138/EC of the European Parliament and of the Council of 25 November 2009 on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II))

4


 

V   Announcements

 

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

 

European Commission

2019/C 208/05

Prior notification of a concentration (Case M.9315 — Chr. Hansen/Lonza/JV) ( 1 )

6


 


 

(1)   Text with EEA relevance.

EN

 


IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

19.6.2019   

EN

Official Journal of the European Union

C 208/1


Euro exchange rates (1)

18 June 2019

(2019/C 208/01)

1 euro =


 

Currency

Exchange rate

USD

US dollar

1,1187

JPY

Japanese yen

121,08

DKK

Danish krone

7,4672

GBP

Pound sterling

0,89403

SEK

Swedish krona

10,6413

CHF

Swiss franc

1,1175

ISK

Iceland króna

141,50

NOK

Norwegian krone

9,7795

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,609

HUF

Hungarian forint

322,31

PLN

Polish zloty

4,2592

RON

Romanian leu

4,7232

TRY

Turkish lira

6,5320

AUD

Australian dollar

1,6349

CAD

Canadian dollar

1,5016

HKD

Hong Kong dollar

8,7643

NZD

New Zealand dollar

1,7192

SGD

Singapore dollar

1,5338

KRW

South Korean won

1 325,56

ZAR

South African rand

16,3782

CNY

Chinese yuan renminbi

7,7486

HRK

Croatian kuna

7,4055

IDR

Indonesian rupiah

16 022,58

MYR

Malaysian ringgit

4,6778

PHP

Philippine peso

58,261

RUB

Russian rouble

71,8787

THB

Thai baht

35,043

BRL

Brazilian real

4,3313

MXN

Mexican peso

21,3935

INR

Indian rupee

78,0005


(1)  Source: reference exchange rate published by the ECB.


19.6.2019   

EN

Official Journal of the European Union

C 208/2


Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1) )

(Text with EEA relevance)

(2019/C 208/02)

Decisions granting an authorisation

Reference of the decision (2)

Date of decision

Substance name

Holder of the authorisation

Authorisation numbers

Authorised use

Date of expiry of review period

Reasons for the decision

C(2019) 4123

12 June 2019

Bis(2-methoxyethyl) ether (diglyme)

EC No: 203-924-4

CAS No 111-96-6

N.V. Ajinomooto OmniChem S.A.

Cooppallaan 91, 9230, Wetteren, Oost Vlaanderen, Belgium

REACH/19/23/0

Use as a solvent for the synthesis of the anti-HIV active pharmaceutical ingredient dapivirine

12 June 2026

Risk is adequately controlled in accordance with Article 60(2) of Regulation (EC) No 1907/2006.

There are no suitable alternatives


(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: http://ec.europa.eu/growth/sectors/chemicals/reach/about/index_en.htm


19.6.2019   

EN

Official Journal of the European Union

C 208/3


Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1) )

(Text with EEA relevance)

(2019/C 208/03)

Decisions granting an authorisation

Reference of the decision (2)

Date of decision

Substance name

Holder of the authorisation

Authorisation numbers

Authorised uses

Date of expiry of review period

Reasons for the decision

C(2019) 4125

12 June 2019

sodium dichromate, (EC No 234-190-3 and CAS No 10588-01-9 (anhydrous); CAS No 7789-12-0 (dihydrate))

H&R Ölwerke Schindler GmbH, Neuhöfer Brückenstr., 127-152, 21107, Hamburg, Germany

REACH/19/18/0

Use of sodium dichromate as corrosion inhibitor in ammonia absorption deep cooling systems, applied for the dewaxing and deoiling process steps of petroleum raffinate

12 June 2031

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socioeconomic benefits outweigh the risk to human health arising from the use of the substance and there are no suitable alternative substances or technologies

H&R Chemisch-Pharmazeutische Spezialitäten GmbH, Neuenkirchener Strasse 8, 48499, Salzbergen, Germany

REACH/19/18/1


(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: http://ec.europa.eu/growth/sectors/chemicals/reach/about/index_en.htm


NOTICES FROM MEMBER STATES

19.6.2019   

EN

Official Journal of the European Union

C 208/4


Winding-Up Proceedings

Decision to start winding-up proceedings in respect of LAMP Insurance Company Limited

(Publication made in accordance with Article 280 of Directive 2009/138/EC of the European Parliament and of the Council of 25 November 2009 on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II))

(2019/C 208/04)

Insurance undertaking

LAMP Insurance Company Limited

Address of registered office:

Suite 822, Europort 8

PO Box 708

Europort Road

Gibraltar

Date, entry into force and nature of decision

On 31 May 2019, the Supreme Court of Gibraltar appointed (with immediate effect) the Official Receiver as liquidator of LAMP Insurance Company Limited under S.160 Insolvency Act 2011.

The Official Receiver has appointed Grant Thornton Gibraltar as Adviser and Agent to undertake the liquidation of LAMP Insurance Company Limited.

The Liquidator through its agent will coordinate with the Financial Services Compensation Scheme in the United Kingdom to ensure that the claims of eligible UK policyholders are processed and submitted to the Compensation Scheme.

The Liquidator through its agent will adjudicate on non UK insurance claims for the admission of such claims in the liquidation estate. Any distribution to insurance creditors may only occur if there has been a successful realisation of assets.

Entry into force: 31 May 2019

Competent authorities

Supreme Court of Gibraltar

The Law Courts

227 Main Street

Gibraltar

Supervisory authority

Gibraltar Financial Services Commission

Suite 3, Ground Floor

Atlantic Suites

Europort Avenue

PO Box 940

Gibraltar

Liquidator appointed

The Official Receiver

H.M. Government of Gibraltar

Treasury Department

206/210 Main Street

Gibraltar

Adviser to the Official Receiver & Agent:

Grant Thornton Gibraltar

6A Queensway

PO Box 64

Gibraltar

Applicable law

Gibraltar law

Financial Services (Insurance Companies) (Solvency II Directive) Act 2015

Insolvency Act 2011

Insolvency Rules 2014

Companies Act 2014


V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

19.6.2019   

EN

Official Journal of the European Union

C 208/6


Prior notification of a concentration

(Case M.9315 — Chr. Hansen/Lonza/JV)

(Text with EEA relevance)

(2019/C 208/05)

1.   

On 11 June 2019, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

Chr. Hansen Holding A/S (‘Chr. Hansen’, Denmark),

Lonza Ltd (‘Lonza’, Switzerland), controlled by Lonza Group Ltd,

A newly created joint venture (the ‘JV’, Switzerland).

Chr. Hansen and Lonza acquire, within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation, joint control over the JV.

The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2.   

The business activities of the undertakings concerned are:

—   for Chr. Hansen: the development of natural solutions for the food, nutritional, pharmaceutical and agricultural industries,

—   for Lonza: the provision of various services from research to final product manufacturing in the pharmaceutical, healthcare and life science industries, including contract development and manufacturing services (‘CDMO’) and services related to drug formulation services and drug delivery technologies,

—   for the JV: the supply of CDMO services to pharmaceutical companies in relation to live biotherapeutic products and phages.

3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.   

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9315 — Chr. Hansen/Lonza/JV

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).